search
Back to results

Immune-Pineal Axis Function in Chronic Tension-Type Headache

Primary Purpose

Chronic Tension-Type Headache

Status
Completed
Phase
Phase 2
Locations
Brazil
Study Type
Interventional
Intervention
Electroacupuncture
Placebo Sham
Sponsored by
Hospital de Clinicas de Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Tension-Type Headache focused on measuring Chronic Tension-Type Headache, Electroacupuncture, Headache Impact, BDNF, TNF

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Women,
  • Aged between 18 and 60 years old,
  • Providing informed consent to participate in the study,
  • Literate,
  • Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.

Exclusion Criteria:

  • Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
  • De-compensated systemic disease,
  • Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),
  • HIV.

Sites / Locations

  • Hospital de Clinicas e Porto Alegre (HCPA)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Electroacupuncture

Placebo Sham

Arm Description

All patients will receive 10 electroacupuncture sessions.

All patients will receive 10 placebo sham sessions.

Outcomes

Primary Outcome Measures

Pain Visual Analogue Scale (VAS)
The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).

Secondary Outcome Measures

Headache Impact Test (HIT-6)
This test was developed in 2004, and has equivalent psychometric properties in nine languages, including Portuguese. It consists of six questions that assess the impact of headache on the ability to work, study, home and in social situations.

Full Information

First Posted
September 15, 2013
Last Updated
November 15, 2013
Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Rio Grande do Sul, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
search

1. Study Identification

Unique Protocol Identification Number
NCT01954277
Brief Title
Immune-Pineal Axis Function in Chronic Tension-Type Headache
Official Title
Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture
Study Type
Interventional

2. Study Status

Record Verification Date
September 2013
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
October 2013 (Actual)
Study Completion Date
November 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital de Clinicas de Porto Alegre
Collaborators
Federal University of Rio Grande do Sul, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.
Detailed Description
Tension-type headache can be defined as a constant sensation of pressure or heaviness, and is a highly-prevalent condition in the health services. The objective of the present study is to investigate the function of the immuno-pineal axis in chronic tension headache, focussed on the neuro-immune regulatory dysfunction. In addition, the effect of neuro-stimulation (electroacupuncture) on the function of this axis will also be studied. This is a clinical Trial study, randomised, in parallel, cross-over with a blinded assessor, and with a sham placebo control. The study will be carried out in the Clinical Research Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), with women aged between 18 and 60 years old. The participants will respond to questionnaires at the beginning and end of each therapeutic intervention, with 24-hour urine, blood and saliva collection. The therapeutic intervention will include: 10 electroacupuncture sessions and 10 sham placebo sessions. The measurements taken will be: quality of life, depression, impact of headache on daily life, sleep quality, chronotropic types, immuno-inflammatory mediators, levels of 6-sulfatoxymelatonin, and salivary cortisol. Through these interventions it is hoped that patients will present an improvement in their pain presentation, quality of life and sleep, as well as central autonomic regulation. Evidence for these hypotheses will support a minimally-invasive treatment, with few side-effects and a low cost.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Tension-Type Headache
Keywords
Chronic Tension-Type Headache, Electroacupuncture, Headache Impact, BDNF, TNF

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
34 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Electroacupuncture
Arm Type
Experimental
Arm Description
All patients will receive 10 electroacupuncture sessions.
Arm Title
Placebo Sham
Arm Type
Sham Comparator
Arm Description
All patients will receive 10 placebo sham sessions.
Intervention Type
Device
Intervention Name(s)
Electroacupuncture
Other Intervention Name(s)
Electrical acupuncture
Intervention Description
Eletroacupuncture performed using acupuncture needles.
Intervention Type
Device
Intervention Name(s)
Placebo Sham
Other Intervention Name(s)
Placebo, Sham
Intervention Description
Placebo Sham is performed using electrodes, without electrical stimulation. Lights and sounds were identical to active treatment.
Primary Outcome Measure Information:
Title
Pain Visual Analogue Scale (VAS)
Description
The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).
Time Frame
An expected average of 3 months. (At baseline and at the end of each intervention period).
Secondary Outcome Measure Information:
Title
Headache Impact Test (HIT-6)
Description
This test was developed in 2004, and has equivalent psychometric properties in nine languages, including Portuguese. It consists of six questions that assess the impact of headache on the ability to work, study, home and in social situations.
Time Frame
An expected average of 3 months. (At baseline and at the end of each intervention period).
Other Pre-specified Outcome Measures:
Title
Biomarkers (BDNF nd TNF)
Description
The BDNF and the TNF will be measured by ELISA.
Time Frame
An expected average of 3 months. (At baseline and at the end of each intervention period).

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women, Aged between 18 and 60 years old, Providing informed consent to participate in the study, Literate, Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society. Exclusion Criteria: Psychiatric or neurologic disorder that unable patient to consent and follow study protocol, De-compensated systemic disease, Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis), HIV.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wolnei Caumo, MD, PhD
Organizational Affiliation
Hospital de Clinicas de Porto Alegre
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Mônica Chassot
Organizational Affiliation
Federal University of Health Science of Porto Alegre
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Francislea C. Sehn
Organizational Affiliation
Federal University of Health Science of Porto Alegre
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rafael Vercelino
Organizational Affiliation
Federal University of Health Science of Porto Alegre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital de Clinicas e Porto Alegre (HCPA)
City
Porto Alegre
State/Province
Rio Grande do Sul
ZIP/Postal Code
90035-003
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Immune-Pineal Axis Function in Chronic Tension-Type Headache

We'll reach out to this number within 24 hrs